Literature DB >> 11438887

Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21.

J D McKay1, F Lesueur, L Jonard, A Pastore, J Williamson, L Hoffman, J Burgess, A Duffield, M Papotti, M Stark, H Sobol, B Maes, A Murat, H Kääriäinen, M Bertholon-Grégoire, M Zini, M A Rossing, M E Toubert, F Bonichon, M Cavarec, A M Bernard, A Boneu, F Leprat, O Haas, C Lasset, M Schlumberger, F Canzian, D E Goldgar, G Romeo.   

Abstract

The familial form of nonmedullary thyroid carcinoma (NMTC) is a complex genetic disorder characterized by multifocal neoplasia and a higher degree of aggressiveness than its sporadic counterpart. In a large Tasmanian pedigree (Tas1) with recurrence of papillary thyroid carcinoma (PTC), the most common form of NMTC, an extensive genomewide scan revealed a common haplotype on chromosome 2q21 in seven of the eight patients with PTC. To verify the significance of the 2q21 locus, we performed linkage analysis in an independent sample set of 80 pedigrees, yielding a multipoint heterogeneity LOD score (HLOD) of 3.07 (alpha=0.42), nonparametric linkage (NPL) 3.19, (P=.001) at marker D2S2271. Stratification based on the presence of at least one case of the follicular variant of PTC, the phenotype observed in the Tas1 family, identified 17 such pedigrees, yielding a maximal HLOD score of 4.17 (alpha=0.80) and NPL=4.99 (P=.00002) at markers AFMa272zg9 and D2S2271, respectively. These results indicate the existence of a susceptibility locus for familial NMTC on chromosome 2q21.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11438887      PMCID: PMC1235316          DOI: 10.1086/321979

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  35 in total

1.  Structural abnormalities of chromosome 2 in benign thyroid tumors. Three new cases and review of the literature.

Authors:  S Bol; G Belge; B Thode; S Bartnitzke; J Bullerdiek
Journal:  Cancer Genet Cytogenet       Date:  1999-10-01

2.  PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected].

Authors:  T G Kroll; P Sarraf; L Pecciarini; C J Chen; E Mueller; B M Spiegelman; J A Fletcher
Journal:  Science       Date:  2000-08-25       Impact factor: 47.728

3.  The changing incidence and spectrum of thyroid carcinoma in Tasmania (1978-1998) during a transition from iodine sufficiency to iodine deficiency.

Authors:  J R Burgess; T Dwyer; K McArdle; P Tucker; D Shugg
Journal:  J Clin Endocrinol Metab       Date:  2000-04       Impact factor: 5.958

4.  Histology of familial thyroid tumours linked to a gene mapping to chromosome 19p13.2.

Authors:  H R Harach; F Lesueur; P Amati; A Brown; F Canzian; J L Kraimps; P Levillain; E Menet; G Romeo; D Bonneau
Journal:  J Pathol       Date:  1999-11       Impact factor: 7.996

5.  Identification of novel deletion regions on chromosome arms 2q and 6p in breast carcinomas by amplotype analysis.

Authors:  Z Piao; K S Lee; H Kim; M Perucho; S Malkhosyan
Journal:  Genes Chromosomes Cancer       Date:  2001-02       Impact factor: 5.006

Review 6.  Familial thyroid cancer.

Authors:  O Alsanea; O H Clark
Journal:  Curr Opin Oncol       Date:  2001-01       Impact factor: 3.645

7.  Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome.

Authors:  C D Malchoff; M Sarfarazi; B Tendler; F Forouhar; G Whalen; V Joshi; A Arnold; D M Malchoff
Journal:  J Clin Endocrinol Metab       Date:  2000-05       Impact factor: 5.958

8.  Chromosomal localization and cDNA sequence of human ralB, a GTP binding protein.

Authors:  C L Hsieh; A Swaroop; U Francke
Journal:  Somat Cell Mol Genet       Date:  1990-07

9.  A candidate prostate cancer susceptibility gene at chromosome 17p.

Authors:  S V Tavtigian; J Simard; D H Teng; V Abtin; M Baumgard; A Beck; N J Camp; A R Carillo; Y Chen; P Dayananth; M Desrochers; M Dumont; J M Farnham; D Frank; C Frye; S Ghaffari; J S Gupte; R Hu; D Iliev; T Janecki; E N Kort; K E Laity; A Leavitt; G Leblanc; J McArthur-Morrison; A Pederson; B Penn; K T Peterson; J E Reid; S Richards; M Schroeder; R Smith; S C Snyder; B Swedlund; J Swensen; A Thomas; M Tranchant; A M Woodland; F Labrie; M H Skolnick; S Neuhausen; J Rommens; L A Cannon-Albright
Journal:  Nat Genet       Date:  2001-02       Impact factor: 38.330

10.  LRP-DIT, a putative endocytic receptor gene, is frequently inactivated in non-small cell lung cancer cell lines.

Authors:  C X Liu; S Musco; N M Lisitsina; E Forgacs; J D Minna; N A Lisitsyn
Journal:  Cancer Res       Date:  2000-04-01       Impact factor: 12.701

View more
  55 in total

1.  Evidence for interaction between the TCO and NMTC1 loci in familial non-medullary thyroid cancer.

Authors:  J D McKay; D Thompson; F Lesueur; K Stankov; A Pastore; C Watfah; S Strolz; G Riccabona; R Moncayo; G Romeo; D E Goldgar
Journal:  J Med Genet       Date:  2004-06       Impact factor: 6.318

Review 2.  Familial follicular cell tumors: classification and morphological characteristics.

Authors:  Vânia Nosé
Journal:  Endocr Pathol       Date:  2010-12       Impact factor: 3.943

3.  Unraveling the genetic predisposition to differentiated thyroid carcinoma.

Authors:  Albert de la Chapelle
Journal:  J Clin Endocrinol Metab       Date:  2013-10       Impact factor: 5.958

Review 4.  Controversies in familial thyroid cancer 2014.

Authors:  Orlo H Clark
Journal:  Ulus Cerrahi Derg       Date:  2014-06-01

5.  The role of microRNA genes in papillary thyroid carcinoma.

Authors:  Huiling He; Krystian Jazdzewski; Wei Li; Sandya Liyanarachchi; Rebecca Nagy; Stefano Volinia; George A Calin; Chang-Gong Liu; Kaarle Franssila; Saul Suster; Richard T Kloos; Carlo M Croce; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

Review 6.  [Hereditary thyroid cancer].

Authors:  H Dralle; A Machens; K Lorenz
Journal:  Chirurg       Date:  2008-11       Impact factor: 0.955

7.  A susceptibility locus for papillary thyroid carcinoma on chromosome 8q24.

Authors:  Huiling He; Rebecca Nagy; Sandya Liyanarachchi; Hong Jiao; Wei Li; Saul Suster; Juha Kere; Albert de la Chapelle
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

Review 8.  The impact of family history on non-medullary thyroid cancer.

Authors:  I J Nixon; C Suárez; R Simo; A Sanabria; P Angelos; A Rinaldo; J P Rodrigo; L P Kowalski; D M Hartl; M L Hinni; J P Shah; A Ferlito
Journal:  Eur J Surg Oncol       Date:  2016-08-11       Impact factor: 4.424

9.  SRGAP1 is a candidate gene for papillary thyroid carcinoma susceptibility.

Authors:  Huiling He; Agnieszka Bronisz; Sandya Liyanarachchi; Rebecca Nagy; Wei Li; Yungui Huang; Keiko Akagi; Motoyasu Saji; Dorota Kula; Anna Wojcicka; Nikhil Sebastian; Bernard Wen; Zbigniew Puch; Michal Kalemba; Elzbieta Stachlewska; Malgorzata Czetwertynska; Joanna Dlugosinska; Kinga Dymecka; Rafal Ploski; Marek Krawczyk; Patrick J Morrison; Matthew D Ringel; Richard T Kloos; Krystian Jazdzewski; David E Symer; Veronica J Vieland; Michael Ostrowski; Barbara Jarząb; Albert de la Chapelle
Journal:  J Clin Endocrinol Metab       Date:  2013-03-28       Impact factor: 5.958

10.  Loss of heterozygosity at 19p13.2 and 2q21 in tumours from familial clusters of non-medullary thyroid carcinoma.

Authors:  Hugo João Prazeres; Fernando Rodrigues; Paula Soares; Plamen Naidenov; Paulo Figueiredo; Beatriz Campos; Manuela Lacerda; Teresa C Martins
Journal:  Fam Cancer       Date:  2007-09-07       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.